Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution... – Containing or obtained from a tree having matured height of...
Reexamination Certificate
2002-04-18
2003-08-26
Tate, Christopher R. (Department: 1651)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
Containing or obtained from a tree having matured height of...
C424S774000, C424S725000
Reexamination Certificate
active
06610332
ABSTRACT:
FIELD OF INVENTION
This invention relates to the treatment of leishmaniasis in animals including human beings, preferably, the extract of betel leaf is used for the treatment of leishmaniasis in human beings. Chemotherapy for visceral leishmaniasis has seen little progress in recent years. Antileishmanicidal activity of betel leaf extracts suggests its potential use to treat human visceral leishmaniasis.
BACKGROUND AND PRIOR ART REFERENCES
Leishmaniasis commonly known as kala-azar as known in India is a global health problem. Infection by various species and strains of Leishmania causes a wide spectrum of disease in humans, with many different clinical presentations. The severity of the disease is largely dictated by the immunological status of the infected individual and by the species of Leishmania involved. Approximately 350 million people in 80 countries are estimated to be threatened by the disease. The World Health Organization (WHO) estimated 12 million cases of leishmaniasis worldwide, with over 400,000 new cases each year. The visceral form of leishmaniasis, or kala-azar, is caused by the parasite
Leishmania donovani
and is often fatal. Despite tremendous progress made in understanding the biochemistry and molecular biology of Leishmania species, treatment by chemotherapy has seen very little progress in recent years. The toxic pentavalent antimonials remain the mainstay of treatment for leishmaniasis. The second line drugs, pentamidine and amphotericin B, although used clinically, have serious toxic side effects. Therefore, improved drug therapy for leishmaniasis remains desirable. Indolylquinoline derivatives have recently been shown cytotoxic to
Leishmania donovani
promastigotes and amastigotes in vitro and are effective in treating murine visceral leishmaniasis (Ganes Chakrabarti, Anirban Basu, Partha Pratim Manna, Sashi Bhusahan Mahato, Nirup Bikash Mandal and Santu Bandyopadhyay,
Journal of Antimicrobial Chemotherapy
(1999) Vol. 43 pp.359-366).
Betel leaves have a strong pungent aromatic flavor and are widely used as a masticatory. Generally, mature or over mature leaves, which have ceased growing but not yet become brittle are used for chewing. The basic preparation for chewing purposes consists of betel leaf smeared with hydrated lime and catechu to which scrapings of arecanut are added; flavorings such as coconut shavings, clove, cardamom, fennel, powdered liquorice, nutmeg and also tobacco are used according to one's taste. In some places prepared pan is covered with silver or gold leaf. As a masticatory, it is credited with many properties: it is aromatic, digestive, stimulant and carminative. Medicinally, it is useful in catarrhal and pulmonary affections; it is also used for poultices. The effects of chewing of betel with arecanut and other adjuncts are the excitation of the salivary glands and the irritation of the mucous membrane of the mouth. The red coloration produced is due to a pigment in the arecanut, which manifests itself under the action of alkali in lime and catechu. A mild degree of stimulation is produced, resulting in a sensation of warmth and well being, besides imparting a pleasant odor. The most important factor determining the aromatic value of the leaf is the amount and particularly the nature of the essential oil present. Betel leaves from different regions vary in smell and taste. The most pungent is the Sanchi type, while the most mild and sweet ones are from Madras. The betel leaves contain essential oils, the content of oil varies from 0.7 to 2.6 per cent depending upon the varieties of leaves. The oil consists of phenols and terpens. The higher the proportion of phenol oil, the better the quality. An isomer of eugenol named chavibetol (betel phenol; 4-allyl-2-hydroxy-1-methoxy benzene) is considered to be the characteristic constituent of betel oil. It is however, absent in Indian samples. Betel oil of Indian types contain as a predominant phenolic constituent. Oil of betel has been used in the treatment of various respiratory catarrhs, as a local application either by gargle or by inhalation in diphtheria. It has carminative properties. It exhibits in different action on the central nervous system of mammals; lethal doses produce deep narcosis leading to death within a few hours. The essential oil and extracts of the leaves possess activity against several Gram-positive and Gram-negative bacteria such as
Micrococcus pyogenes
var.
albus
and var.
aureus, Bacillus subtilis
and
B. megaterium, Diplococcus pneumoniae, Streptococcus pyogenes, Escherichia coli, Salmonella typhosa, Vibrio comma, Shigella dysenteriae, Proteus vulgaris, Pseudomonas solanacaerum, Sarcina lutea
and
Erwinia carotovora.
The essential oil and leaf extracts also showed antifungal activity against
Asperigillus niger
and
A. oryzae, Curvularia lunata
and
Fusarium oxysporum.
The oil is found to be lethal in about 5 minutes to the protozoa
Paramaecium caudatum
(
Wealth of India,
Vol.8, pg.84-94).
OBJECTS OF THE INVENTION
The main object of the invention is to provide a method of treating animals including human beings for leishmaniasis by the way of administering betel leaf extract or lyophilized betel leaf extract.
Another object of the present invention is to provide a composition comprising betel leaf extract, which is useful for the treatment of leishmaniasis of human being.
Yet another object of the present invention is the preparation of the betel leaf water extract.
SUMMARY OF THE INVENTION
To meet the above objects, the invention provides use of betel leaf extract for the treatment of leishmaniasis in human beings and animals.
DETAILED DESCRIPTION
The present invention relates to a composition comprising betel leaf extract, which is useful for the treatment of leishmaniasis of human being and a process for the preparation of the betel leaf water extract. This invention also provides a method of treating the human being for leishmaniasis by the way of administering the extract or lyophilized extract as a composition comprising betel leaf extract along with a pharmaceutically acceptable additive.
Accordingly the invention provides a pharmaceutical composition useful for the treatment of visceral leishmaniasis, or kala-azar as known in India, said composition comprising effective amount of betel leaf extract or lyophilized extract together with or associated with a pharmaceutically acceptable additive.
In another embodiment the additive is selected in such a manner that does not interfere with the activity of betel leaf extract.
In still another embodiment, the additive is selected from nutrients such as proteins, carbohydrates and sugar, talc, magnesium sterate, cellulose, calcium carbonate, starch-gelatin paste and/or pharmaceutically acceptable carriers.
In still another embodiment, the betel leaf extract is administered orally or intramuscularly.
In yet another embodiment, the oral route is in the form of capsule, syrup, concentrate, powder or granules.
In yet another embodiment, the ratio of betel leaf extract to the additive is in the range between 10 to 1.
In yet another embodiment, the betel leaf extract is administered at a dosage level between 10 to 20 mg/kg of body weight for alternate days for one month.
In yet another embodiment, the betel leaf extracts reduce the viability of
L. donovani
promastigotes in vitro by 57 to 79% and reduce splenic and liver parasite load by 93 to 95%.
In yet another embodiment of the present invention, the betel leaf extract or composition is used for the treatment of visceral leishmaniasis or kala-azar.
In yet another embodiment of the present invention, the betel leaf extract or lyophilized extract or composition is administered together with or associated with a pharmaceutically acceptable additive.
In yet another embodiment of the present invention, the additive is selected in such a manner it does not interfere with the activity of betel leaf extract.
In yet another embodiment of the present invention, the additive is selected from nutrients such as proteins, carbohydrates, sugar and
Bandyopadhyay Santu
Bhattacharya Samir
Chandra Roy Keshab
Pal Bikash
Ray Mitali
Council of Scientific and Industrial Research
Fitzpatrick ,Cella, Harper & Scinto
Tate Christopher R.
LandOfFree
Anti-leishmanial activity of betel leaf extract does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-leishmanial activity of betel leaf extract, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-leishmanial activity of betel leaf extract will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3127859